ArticleInternational journal of clinical oncology2022

Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis.

Teruki Isobe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.